Reactosome

California Life Sciences is proud to announce our Fall 2024 FAST cohort! These startups have been selected to receive 12 weeks of business mentoring from expert advisors through California Life Sciences’ advisory program, FAST California. Now in its eleventh year, FAST supports founders of early-stage disruptive and innovative life science startups. Congratulations to all participants and thank you to our program advisors & sponsors for their support. To learn more about these innovative start-ups go here: https://bit.ly/4doFAcx Meet the Fall 2024 FAST California Entrepreneurs:  June Park, Ph.D. of Cenos Therapeutics Bodour Salhia, Ph.D of CpG Diagnostics, Inc. Rinko Ghosh of IHP Therapeutics Divya Chander of Lucidify Aidan Tsai of Neuro Industry Parnian Lak of Olfera Abraham Lin of Orbits Oncology Ksenia Burka of Reactosome Yue Clare Lou, Ph.D. of Sift Biosciences Laura Hsieh, PhD of TippingPoint Biosciences Ugur Eskiocak of Voro Therapeutics Hsian-Rong Tseng of Eximius Diagnostics Corporation Sophia Lugo & Eerik Kaseniit of Radar Therapeutics

We’re excited to share the incredible success of Nucleate Germany's inaugural #Activator Season 2023-24! This #milestone represents 1.5 years of dedicated team effort, innovation, and community building within Germany’s biotech ecosystem. Our first Activator Demo Day in Berlin was a resounding success, reflecting the vibrant and diverse biotech community we have fostered. We extend our heartfelt thanks to all who attended and made it unforgettable – we hope you enjoyed it as much as we did! The evening was filled with remarkable moments, beginning with presentations from this years pioneering startups: Activa.TE, EscapeAGENT, Fluvion, Jellyfish Bio, MIMBIOSIS, Reactosome, RevoBITs, and Silica Corpora. This cohort‘s 8 teams are spearheading groundbreaking advancements in biotechnology, each offering unique solutions and transformative technologies across the biomedical and eco landscape We are excited to announce this year‘s winning teams: 🥇Germany #Activator main prize: RevoBITs 🏆MilliporeSigma Regional High Impact Culture Award: Reactosome 🏆Genentech Regional Diversity, Equity, and Inclusion Prize: EscapeAGENT 🏆Alnylam Pharmaceuticals Regional Scientific Excellence Award: Fluvion 🏆BioLabs Golden Ticket: Reactosome Thank you to our speakers whose insights made this event so remarkable: Ulrike Rauh (Sack) from PROSION Therapeutics and Trueline Therapeutics, Prateek M., CEO of BIOWEG , Jan-Philipp Kruse from Bayer Co.Lab, Dr. Anela Vukoja from Apollo Health Ventures, Univ.-Prof. Dr. Ing. Georg Duda from the Julius Wolff Institute at Charité - Universitätsmedizin Berlin, and Dorothée Marie-Louise Doepfer from BIH Digital Health Accelerator. We extend our deepest gratitude to our sponsors, and especially also to our dedicated mentors and experts who have supported the Activator program throughout the year. Special thanks to Dr. Philipp Marchand, Dr. Andreas Heiseke, Christian Schloerb from VOSSIUS, Carolin Clement from Berlin Partner für Wirtschaft und Technologie GmbH, and Ann-Kristin Mueller and Stefanie Schimmel from BioLabs. As we look to the future, we are excited about the potential we see in the German biotech startup landscape, upcoming Nucleate Germany events and our next Activator season as we continue to explore the forefront of biotech advancements. Join us in our journey to foster innovation, collaboration, and progress in the biotech sector and stay up to date via our newsletter!

Congratulations Reactosome! 🌟 Ksenia Burka and Giorgio Fracasso, your dedication and passion are truly inspiring. The BioLabs Heidelberg team (Ann-Kristin Mueller, Heiner Sähr, Stefanie Schimmel, Ornella Kossi) is honored to support you on your scientific journey. Watching you work tirelessly around the clock to reach your next milestones motivates us all. We are excited to see your future developments and growth. We are convinced that Reactosome will make an impact with the synthetic nuclei technology to deliver AND continuously express very large payloads for gene therapy. The Reactosome platform allows to control multiple parameters across the delivery process, from packaging to duration of expression. Your story so far is a testament to how early-stage companies can thrive at BioLabs within a short time, and how we empower you to drive #innovation forward. 🚀💪🔬✨ #Reactosome #BioLabsHeidelberg #GeneTherapy #EmpoweringInnovation #ScientificJourney #Dedication #Passion #TeamWork #Milestones

Reactosome graduated from the IndieBio SF Batch 15! 🧬 We’ve learned so much and met amazing fellow companies disrupting standards—harnessing the power of the dark proteome, squeezing DNA out of rocks, reversing climate change with cold plasma, achieving the fastest sequencing, and so much more! We are beyond grateful to every IndieBio and SOSV team member for making all of this possible. Just five months ago, Giorgio Fracasso and I had just a crazy idea and determination. Today, we are officially Reactosome, the world’s first synthetic nucleus company. Behind this achievement were countless hours in the lab—from assembling prototypes to witnessing the first glow of RNA expression in cells; calls spanning 9,099 km, filled with business wisdom and human support—late at night and during morning rides to work; challenges that pushed us beyond our comfort zones; negotiating deals; and making endless improvements to ensure our message is clear, loud, and bold. We are now confident that our Synthetic Nucleus will enable a whole new class of genomic medicine—safer, continuous and controllable, with the largest cargo capacity, and suitable for specific cell delivery! Our next goal is to accelerate the R&D up to the preclinical stage and engage with biopharma. Interested in a sneak peek? Check out the video the IndieBio team produced: https://lnkd.in/enKybc7B Feel free to reach out to learn more. We are fundraising and looking for more partners! Loud shoutout to IndieBio SF Batch 15, you are the best: Hypercell Technologies, RyboDyn Inc., BryoSphere Biotechnologies, SpiralWave, AquaLith, Stream Genomics, Farm Minerals, Jolly Mazumdar & Thimmaiah Chendrimada, and Nutrition from Water™ (NXW) #IndieBio #GenomicMedicine #genetherapy #RNA #DNA #Biotech #Fundraising #SyntheticNucleus #Reactosome 

𝗡𝘂𝗰𝗹𝗲𝗮𝘁𝗲 𝗮𝗻𝗱 𝗲𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗕𝗲𝗿𝗹𝗶𝗻 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 🦾🧬 On Friday, Nucleate Germany had our 2024 Activator demo day at MotionLab.Berlin. We aimed to spotlight this year’s impressive Activator teams (Activa.TE, EscapeAGENT, Fluvion, Jellyfish Bio, MIMBIOSIS, Reactosome, RevoBITs, Silica Corpora) as well as bring together Berlin’s biotech community. With over 300 people signed up to the event and an engaged audience of scientists, founders, investors and others in biotech and pharma, it seemed like an exciting step in the direction of growing the Berlin ecosystem 🔬🧪 💊 I’m happy to have had the chance to lead the organization of the event, as well as host it and moderate a panel about the future of Berlin/German biotech. Thanks to the great speakers and panelists for their participation: Ulrike Rauh, Prateek M., Dr. Anela Vukoja Univ.-Prof. Dr. Ing. Georg Duda, Jan-Philipp Kruse, Dorothée Marie-Louise Doepfer Thanks also to this (non-exhaustive) list of Nucleate team members who made the Activator program and demo day possible: Dr. Philipp Stoffers Nico Alavi Sabina Mammadova Suyen Espinoza Miranda, PhD Robin Sayar Julia Nanyi Zhao, PhD Felix Gauhar Bhargavi Jei Kishore Fabio Patrick Aarón Julia Maria Kevin

Get ready for the Nucleate Germany Activator Demo Day! 🚀 June 14th marks the conclusion of the 2023/2024 Activator cycle, and we’re celebrating with a demo day in Berlin. Join us for an evening of pitches from the exciting bio and ecotech teams in this year’s cohort, as well as keynote talks, a panel of experts, and fantastic networking opportunities. Meet the Teams: Activa.TE - Medical device for stimulating and directing endogenous tissue regeneration. EscapeAGENT - High-efficiency gene delivery through an endosomal escape enhancer. Fluvion - Climate-neutral, sustainable, and animal-free biologics and pharmaceuticals manufacturing. Jellyfish Bio - Biomarker discovery platform for genetic diseases. MIMBIOSIS - Mycelium-powered carbon-negative panels from textile waste. Reactosome - Tiny bioreactors for cell reprogramming. RevoBITs - The first smart multi-material bioprinter. Silica Corpora - A generative-AI software platform for developing the next generation of antibody therapeutics.   📆 Save the Date: June 14th 📍 Location: MotionLab.Berlin, Bouchéstrasse 12, Halle 20, 12435 Berlin 💡 RSVP your spot Now:  https://lu.ma/4jksidkp Come and connect with leading biotech experts, enjoy delicious food and drinks! 💫